They conducted a retrospective review of patients who underwent extirpative therapy for RCC recurrence at their high-volume, tertiary-care center between 2006 and 2016. They excluded patients with solitary kidneys, benign pathology, or familial RCC. Local recurrence was defined as a new lesion seen on imaging either within or adjacent to the prior partial nephrectomy bed, and was confirmed by pathology.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
They concluded that laparoscopic completion nephrectomy for locoregional RCC recurrence is feasible, but associated with high rates of open conversion especially in cases with high nephrometry scores and the presence of metastatic disease.
Presented by: Zachary Kozel, MD
Written by: Michael Owyong, Department of Urology, University of California-Irvine at the 2018 AUA Annual Meeting - May 18 - 21, 2018 – San Francisco, CA USA